Yang Seokhun, Kwak Soongu, Song You-Hyun, Han Seung Seok, Lee Hye Sun, Kang Shinae, Lee Seung-Pyo
Division of Cardiology and Cardiovascular Center, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Diabetes Care. 2022 May 1;45(5):1268-1275. doi: 10.2337/dc21-2521.
To analyze the relationship between time-serial changes in insulin resistance and renal outcomes.
A prospective cohort of subjects from the general population without chronic kidney disease (CKD) underwent a biennial checkup for 12 years (n = 5,347). The 12-year duration was divided into a 6-year exposure period, where distinct HOMA for insulin resistance (HOMA-IR) trajectories were identified using latent variable mixture modeling, followed by a 6-year event accrual period, from which the renal outcome data were analyzed. The primary end point was adverse renal outcomes, defined as a composite of estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 in two or more consecutive checkups or albumin ≥1+ on urine strip.
Two distinct groups of HOMA-IR trajectories were identified during the exposure period: stable (n = 4,770) and increasing (n = 577). During the event accrual period, 449 patients (8.4%) developed adverse renal outcomes, and the risk was higher in the increasing HOMA-IR trajectory group than in the stable group (hazard ratio 2.06, 95% CI 1.62-2.60, P < 0.001). The results were similar after adjustment for baseline clinical characteristics, comorbidities, anthropometric and laboratory findings, eGFR, and HOMA-IR. The clinical significance of increasing HOMA-IR trajectory was similar in three or four HOMA-IR trajectories. The increasing tendency of HOMA-IR was persistently associated with a higher incidence of adverse renal outcomes, irrespective of the prevalence of diabetes.
An increasing tendency of insulin resistance was associated with a higher risk of adverse renal outcomes. Time-serial tracking of insulin resistance may help identify patients at high risk for CKD.
分析胰岛素抵抗的时间序列变化与肾脏结局之间的关系。
对来自普通人群且无慢性肾脏病(CKD)的受试者进行前瞻性队列研究,为期12年,每两年进行一次体检(n = 5347)。12年的研究期分为6年的暴露期,在此期间使用潜在变量混合模型确定胰岛素抵抗的不同稳态模型评估胰岛素抵抗(HOMA-IR)轨迹,随后是6年的事件累积期,用于分析肾脏结局数据。主要终点是不良肾脏结局,定义为连续两次或更多次体检中估算肾小球滤过率(eGFR)<60 mL/min/1.73 m² 或尿试纸白蛋白≥1+的综合情况。
在暴露期确定了两组不同的HOMA-IR轨迹:稳定组(n = 4770)和上升组(n = 577)。在事件累积期,449名患者(8.4%)出现了不良肾脏结局,上升HOMA-IR轨迹组的风险高于稳定组(风险比2.06,95% CI 1.62 - 2.60,P < 0.001)。在调整基线临床特征、合并症、人体测量和实验室检查结果、eGFR和HOMA-IR后,结果相似。在三或四条HOMA-IR轨迹中,HOMA-IR上升轨迹的临床意义相似。无论糖尿病的患病率如何,HOMA-IR的上升趋势一直与不良肾脏结局的较高发生率相关。
胰岛素抵抗的上升趋势与不良肾脏结局的较高风险相关。对胰岛素抵抗进行时间序列跟踪可能有助于识别CKD高危患者。